These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3263645)

  • 21. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype.
    Aalto-Setälä K; Helve E; Kovanen PT; Kontula K
    J Clin Invest; 1989 Aug; 84(2):499-505. PubMed ID: 2760198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two partial deletion mutations involving the same Alu sequence within intron 8 of the LDL receptor gene in Korean patients with familial hypercholesterolemia.
    Chae JJ; Park YB; Kim SH; Hong SS; Song GJ; Han KH; Namkoong Y; Kim HS; Lee CC
    Hum Genet; 1997 Feb; 99(2):155-63. PubMed ID: 9048913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum.
    Lehrman MA; Schneider WJ; Brown MS; Davis CG; Elhammer A; Russell DW; Goldstein JL
    J Biol Chem; 1987 Jan; 262(1):401-10. PubMed ID: 3025214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a disease-causing Glu119-Lys mutation in the low-density lipoprotein receptor gene in two Danish families with heterozygous familial hypercholesterolemia.
    Jensen HK; Jensen TG; Jensen LG; Hansen PS; Kjeldsen M; Andresen BS; Nielsen V; Meinertz H; Hansen AB; Bolund L
    Hum Mutat; 1994; 4(2):102-13. PubMed ID: 7981713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective processing and binding of low-density lipoprotein receptors in fibroblasts from a familial hypercholesterolaemic subject.
    Knight BL; Gavigan SJ; Soutar AK; Patel DD
    Eur J Biochem; 1989 Feb; 179(3):693-8. PubMed ID: 2920733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian origin.
    Rubinsztein DC; Jialal I; Leitersdorf E; Coetzee GA; van der Westhuyzen DR
    Biochim Biophys Acta; 1993 Aug; 1182(1):75-82. PubMed ID: 8347689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.
    Daly NL; Scanlon MJ; Djordjevic JT; Kroon PA; Smith R
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6334-8. PubMed ID: 7603991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.
    Miyake Y; Tajima S; Yamamura T; Yamamoto A
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5151-5. PubMed ID: 6272292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia.
    Bihain BE; Yen FT
    Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exon-Alu recombination deletes 5 kilobases from the low density lipoprotein receptor gene, producing a null phenotype in familial hypercholesterolemia.
    Lehrman MA; Russell DW; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3679-83. PubMed ID: 3012527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of induced deletion of repeats in binding domain of the VLDL receptor on its ligand-binding capacity].
    Liu ZG; Qu S; Feng N; Zong YQ; Deng YZ; Feng ZC
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):158-64. PubMed ID: 12006989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.
    Hobbs HH; Leitersdorf E; Goldstein JL; Brown MS; Russell DW
    J Clin Invest; 1988 Mar; 81(3):909-17. PubMed ID: 3343347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia.
    Lelli N; Ghisellini M; Gualdi R; Tiozzo R; Calandra S; Gaddi A; Ciarrocchi A; Arca M; Fazio S; Coviello DA
    Arterioscler Thromb; 1991; 11(2):234-43. PubMed ID: 1998642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.
    Takahashi S; Kawarabayasi Y; Nakai T; Sakai J; Yamamoto T
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9252-6. PubMed ID: 1384047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and in vitro functional evaluation of a low-density lipoprotein receptor/transferrin fusion protein as a therapeutic tool for familial hypercholesterolemia.
    Parise F; Simone L; Croce MA; Ghisellini M; Battini R; Borghi S; Tiozzo R; Ferrari S; Calandra S; Ferrari S; Calandra S; Ferrari S
    Hum Gene Ther; 1999 May; 10(7):1219-28. PubMed ID: 10340553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hypercholesterolemia. Evidence for a newly recognized mutation determining increased fibroblast receptor affinity but decreased capacity for low density lipoprotein in two siblings.
    Ostlund RE; Levy RA; Witztum JL; Schonfeld G
    J Clin Invest; 1982 Oct; 70(4):823-31. PubMed ID: 6288770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.
    Davis CG; Lehrman MA; Russell DW; Anderson RG; Brown MS; Goldstein JL
    Cell; 1986 Apr; 45(1):15-24. PubMed ID: 3955657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repetitive sequences involved in the recombination leading to deletion of exon 5 of the low-density-lipoprotein receptor gene in a patient with familial hypercholesterolemia.
    Rüdiger NS; Hansen PS; Jørgensen M; Faergeman O; Bolund L; Gregersen N
    Eur J Biochem; 1991 May; 198(1):107-11. PubMed ID: 2040272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.